[
    "{\"step_by_step_thinking\": \"Document [0] mentions that KAT2A was identified as a therapeutic target in AML. Document [1] also mentions that Kat2a is a genetic vulnerability in AML. Document [4] also mentions that KAT2A was identified as a therapeutic target in AML. Therefore, it is clear that KAT2A is involved in Acute myeloid leukemia (AML).\", \"answer_choice\": \"A\"}"
]